Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1978 1
1979 1
1980 1
1981 3
1982 1
1993 1
2001 1
2003 3
2006 1
2007 2
2009 2
2011 2
2012 7
2013 6
2014 16
2015 24
2016 40
2017 64
2018 89
2019 123
2020 77
Text availability
Article attribute
Article type
Publication date

Search Results

410 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Devinsky O, et al. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Epilepsia. 2014. PMID: 24854329 Free PMC article. Review.
To present a summary of current scientific evidence about the cannabinoid, cannabidiol (CBD) with regard to its relevance to epilepsy and other selected neuropsychiatric disorders. ...Trials in other treatment-resistant epilepsies may also be warranted. A Pow …
To present a summary of current scientific evidence about the cannabinoid, cannabidiol (CBD) with regard to its relevance to epile
Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy.
Samanta D. Samanta D. Pediatr Neurol. 2019 Jul;96:24-29. doi: 10.1016/j.pediatrneurol.2019.03.014. Epub 2019 Mar 22. Pediatr Neurol. 2019. PMID: 31053391 Review.
However, the prognosis of epilepsy remains unchanged, with approximately one-third of patients continuing to have drug-resistant seizures. ...Cannabidiol can cause liver enzyme elevation, especially when co-administered with valproate. The US Food and Drug Administr …
However, the prognosis of epilepsy remains unchanged, with approximately one-third of patients continuing to have drug-resistant seiz …
Cannabidiol (Epidiolex) for epilepsy.
Med Lett Drugs Ther. 2018 Nov 5;60(1559):182-184. Med Lett Drugs Ther. 2018. PMID: 30681657 No abstract available.
The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
Reddy DS. Reddy DS. Clin Pharmacol Ther. 2017 Feb;101(2):182-184. doi: 10.1002/cpt.441. Epub 2016 Sep 29. Clin Pharmacol Ther. 2017. PMID: 27506704 Review.
Cannabis-derived cannabinoids such as cannabidiol (CBD) have anticonvulsant properties. Recently, there has been an emerging interest in the use of CBD-enriched products for treatment of drug-resistant epilepsy. ...This review briefly describes the clinical utility …
Cannabis-derived cannabinoids such as cannabidiol (CBD) have anticonvulsant properties. Recently, there has been an emerging interest …
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy.
Franco V, Perucca E. Franco V, et al. Drugs. 2019 Sep;79(13):1435-1454. doi: 10.1007/s40265-019-01171-4. Drugs. 2019. PMID: 31372958 Review.
Cannabidiol (CBD) is a major active component of the Cannabis plant, which, unlike tetrahydrocannabinol (THC), is devoid of euphoria-inducing properties. During the last 10 years, there has been increasing interest in the use of CBD-enriched products for the treatment of
Cannabidiol (CBD) is a major active component of the Cannabis plant, which, unlike tetrahydrocannabinol (THC), is devoid of euphoria-
Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP, Bebin EM. Szaflarski JP, et al. Epilepsy Behav. 2014 Dec;41:277-82. doi: 10.1016/j.yebeh.2014.08.135. Epub 2014 Oct 1. Epilepsy Behav. 2014. PMID: 25282526 Review.
Recreational cannabis use in adults with epilepsy is widespread. The use of cannabis for medicinal purposes is also becoming more prevalent. ...The recent changes in the legal environment have improved the availability of products with high cannabidiol (CBD) and low …
Recreational cannabis use in adults with epilepsy is widespread. The use of cannabis for medicinal purposes is also becoming more pre …
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.
Silvestro S, Mammana S, Cavalli E, Bramanti P, Mazzon E. Silvestro S, et al. Molecules. 2019 Apr 12;24(8):1459. doi: 10.3390/molecules24081459. Molecules. 2019. PMID: 31013866 Free PMC article. Review.
Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from Cannabis sativa. CBD is a terpenophenol and it has received a great scientific interest thanks to its medical applications. ...The purpose of this paper is to evaluate the use of CBD,
Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from Cannabis sativa. CBD is a terpenophenol and
Cannabidiol and epilepsy: Rationale and therapeutic potential.
Leo A, Russo E, Elia M. Leo A, et al. Pharmacol Res. 2016 May;107:85-92. doi: 10.1016/j.phrs.2016.03.005. Epub 2016 Mar 11. Pharmacol Res. 2016. PMID: 26976797 Review.
Therefore, the need for different other therapeutic options to manage epilepsy is still a current issue. To this purpose, emphasis has been given to phytocannabinoids, which have been medicinally used since ancient time in the treatment of neurological disorders including …
Therefore, the need for different other therapeutic options to manage epilepsy is still a current issue. To this purpose, emphasis ha …
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.
Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, Silvestrini M. Lattanzi S, et al. Drugs. 2018 Nov;78(17):1791-1804. doi: 10.1007/s40265-018-0992-5. Drugs. 2018. PMID: 30390221
BACKGROUND: Approximately one-third of patients with epilepsy presents seizures despite adequate treatment. Hence, there is the need to search for new therapeutic options. ...METHODS: Randomized, placebo-controlled, single- or double-blinded add-on trials of oral CBD in pa …
BACKGROUND: Approximately one-third of patients with epilepsy presents seizures despite adequate treatment. Hence, there is the need …
Cannabidiol as a treatment for epilepsy.
Pickrell WO, Robertson NP. Pickrell WO, et al. J Neurol. 2017 Dec;264(12):2506-2508. doi: 10.1007/s00415-017-8663-0. J Neurol. 2017. PMID: 29124331 Free PMC article. No abstract available.
410 results
Jump to page
Feedback